Clinically guided plans with prescription treatments - tailored to support sustainable weight loss and long-term results.
Only available if prescribed after an online consultation with a healthcare provider. Benefits outlined are based on third-party studies. Plans are offered as a subscription service which can be canceled at any time. Actual product packaging may appear differently than shown. The FDA does not review or approve any compounded medications for safety or effectiveness. These treatments are individualized and do not guarantee specific results. Provider-determined, off-label use may apply.
Take our easy 3-minute questionnaire
Consult with a medical provider to determine a treatment plan
Receive your personalized prescription medications (upon eligibility)
Enjoy ongoing care, support, and treatment optimization
Every plan is personalized to support your unique biology and lifestyle. Providers may include medications for:
Appetite awareness
Blood sugar support
Mood & craving support
Digestive and metabolic routine
Energy & focus
Disclaimer: Only included if medically appropriate. Compounded ingredients are not FDA-approved.
Our medication is delivered from a state licensed pharmacy in our network, right to your door when you need it.
Our pharmacies perform third party testing through FDA and DEA registered labs to run quality control checks for every compounded lot prescribed for Eden patients. They test four key characteristics that are associated with quality and safety.
Your health and well-being are our absolute top priority. That is why we never avoid any effort to ensure you get the best treatment every time, starting from day one.
Eden connects patients with licensed providers who may prescribe medication through state-licensed pharmacies. Prescription medication only available if prescribed after an online consultation with a healthcare provider. Physicians may prescribe compounded medications as needed to meet patient requirements or drug shortages. The FDA does not review or approve any compounded medications for safety or effectiveness. Results may vary.
Plans are offered as a subscription service which you can cancel at any time. Actual product packaging may appear differently than shown.
The New England Journal of Medicine: Reduction in the Incidence of Type 2 Diabetes with Lifestyle Intervention or Metformin
American College of Physicians: Annals of Internal Medicine: Long-Term Weight Loss With Metformin or Lifestyle Intervention in the Diabetes Prevention Program Outcomes Study
Oxford Academic: Human Reproduction: Metformin reduces pregnancy complications without affecting androgen levels in pregnant polycystic ovary syndrome women: results of a randomized study
The Lancet: Effect of naltrexone plus bupropion on weight loss in overweight and obese adults (COR-I): a multicentre, randomised, double-blind, placebo-controlled, phase 3 trial
Obesity: A Research Journal: A Randomized, Phase 3 Trial of Naltrexone SR/Bupropion SR on Weight and Obesity-related Risk Factors (COR-II)
Obesity: A Research Journal: Bupropion SR enhances weight loss: a 48-week double-blind, placebo- controlled trial
Obesity: A Research Journal: Bupropion for weight loss: an investigation of efficacy and tolerability in overweight and obese women
American Heart Association: Stroke: Acarbose slows progression of intima-media thickness of the carotid arteries in subjects with impaired glucose tolerance
Journal of the American Medical Association: Weight Control and Risk Factor Reduction in Obese Subjects Treated for 2 Years With Orlistat
American College of Physicians: Annals of Internal Medicine: Long-term Weight Loss with Metformin or Lifestyle Intervention in the Diabetes Prevention Program Outcomes Study
Obesity: A Research Journal: Weight Loss With Naltrexone SR/Bupropion SR Combination Therapy as an adjunct to Behavior Modification: The COR-BMOD Trial
Mayo Clinic: Pyridoxine (oral route, injection route)
BMJ Journals: Openheart: Myo-inositol for insulin resistance, metabolic syndrome, polycystic ovary syndrome and gestational diabetes
Mayo Clinic: Acarbose (oral route)
StatPearls: Orlistat
National Institutes of Health: Carnitine
